valproic acid and veliparib

valproic acid has been researched along with veliparib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Khanna, KK; Lim, YC; Ward, A; Wiegmans, AP; Yap, PY	1

Other Studies

2 other study(ies) available for valproic acid and veliparib

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition. Molecular cancer therapeutics, 2015, Volume: 14, Issue:10 Topics: Antineoplastic Agents; Benzimidazoles; BRCA1 Protein; Cell Line, Tumor; Cell Survival; Depsipeptides; DNA Damage; DNA Repair Enzymes; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Fanconi Anemia Complementation Group D2 Protein; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Genomic Instability; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rad51 Recombinase; Recombinational DNA Repair; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Valproic Acid; Vorinostat	2015

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

Topics: Antineoplastic Agents; Benzimidazoles; BRCA1 Protein; Cell Line, Tumor; Cell Survival; Depsipeptides; DNA Damage; DNA Repair Enzymes; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Fanconi Anemia Complementation Group D2 Protein; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Genomic Instability; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rad51 Recombinase; Recombinational DNA Repair; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Valproic Acid; Vorinostat

2015